Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medicamen Biotech has informed the exchanges that its trading window will be closed from April 1, 2026, until 48 hours after the declaration of audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. During this period, all directors, designated persons, and connected persons are prohibited from trading in the company's securities. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, typically enforced ahead of financial result announcements. The board meeting date to approve the audited results will be communicated separately.
This is a standard regulatory filing and does not have a direct impact on shareholders or stock price. Investors should note that audited FY26 results are expected to be announced in the coming weeks, which could be a significant catalyst for the stock.